In this interview from our Institute for Value-Based Medicine® event, held in partnership with the Zangmeister Cancer Center of Columbus, Ohio, on September 14, Kristine Slam, MD, FACP, Central Ohio Surgical Associates, discusses the benefits of value-based care in the breast cancer space.
In this interview from our Institute for Value-Based Medicine® event, held in partnership with the Zangmeister Cancer Center of Columbus, Ohio, on September 14, Kristine Slam, MD, FACP, breast cancer surgeon and partner at Central Ohio Surgical Associates, discusses the benefits of value-based care in the breast cancer space.
Transcript
Can you discuss the importance of investigating patient costs from breast cancer?
Breast cancer is actually the most expensive cancer that we treat in America. And as a breast cancer surgeon, I'm a fixer. I like to surgically resect tumors, and we fix the problem pretty quickly. So, one of the struggles that my patients have is cost of care, financial toxicity. I became very interested in this a couple years ago, because as a fixer, that is something we cannot quickly fix.
How does implementation of a value-based care model improve the quality of breast cancer treatments and patient outcomes?
A value-based care model, what it does is it really brings the patient forefront and center; it requires a collaborative approach. In the breast cancer world, this is typically done through a multidisciplinary tumor board. What we're looking at is specifically tailoring the therapy to the patient, appropriate care, appropriate surgery, [and] de-escalation of therapy when possible, which also eliminates both short-term and long-term side effects and financial repercussions.
Real-World Data Show Sotorasib Effective for NSCLC With KRAS Mutation
May 18th 2024Data from real-world and clinical-trial settings on frontline monotherapy treatment with the KRAS inhibitor sotorasib both show similar progression-free survivals and a high likelihood that the treatment’s efficacy is not affected with dose reduction.
Read More
Health Equity and Access Weekly Roundup: May 18, 2024
May 18th 2024The US Senate hosted a panel addressing physician and health care shortages and efforts to increase minority representation in the medical field. An expert discussed initiatives to prevent senior homelessness. Advocates called for the repeal of the Comstock Act. Regulatory reforms are called for to improve rural cancer patients' access to pharmacies. Research reveals the impact of denials on patient access to immunology treatments.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More